| scholarly article | Q13442814 |
| P50 | author | Douglas Arenberg | Q57042266 |
| P2093 | author name string | M D Burdick | |
| R M Strieter | |||
| S L Kunkel | |||
| Y Y Xue | |||
| D A Arenberg | |||
| M P Keane | |||
| S B Morris | |||
| M D Iannettoni | |||
| B DiGiovine | |||
| M C Glass | |||
| P2860 | cites work | Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides | Q24298587 |
| Endostatin: an endogenous inhibitor of angiogenesis and tumor growth | Q24315369 | ||
| Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8 | Q24675647 | ||
| Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo | Q24678892 | ||
| Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins | Q28251702 | ||
| The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis | Q34662335 | ||
| Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines | Q35452938 | ||
| Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome | Q35764135 | ||
| Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. | Q35764209 | ||
| Distributions of melanoma growth stimulatory activity of growth-regulated gene and the interleukin-8 receptor B in human wound repair | Q35795557 | ||
| Intratumor microvessel density as a prognostic factor in cancer | Q35796301 | ||
| Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung | Q35817557 | ||
| Tumor dormancy in vivo by prevention of neovascularization | Q36271710 | ||
| Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma | Q36363086 | ||
| The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation | Q36365144 | ||
| Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases | Q36367319 | ||
| Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis | Q36380713 | ||
| Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer | Q36799412 | ||
| Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice | Q37356393 | ||
| Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis | Q40377374 | ||
| Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression | Q41640097 | ||
| Interleukin-8 as a macrophage-derived mediator of angiogenesis | Q44053300 | ||
| Activated macrophages induce vascular proliferation | Q53988557 | ||
| Relation of neovascularisation to metastasis of non-small-cell lung cancer | Q59219829 | ||
| The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA | Q67577299 | ||
| Thiol-containing compounds inhibit the production of monocyte/macrophage-derived angiogenic activity | Q67713400 | ||
| Stimulation of neovascularization by human rheumatoid synovial tissue macrophages | Q68962580 | ||
| Angiostatin induces and sustains dormancy of human primary tumors in mice | Q71101907 | ||
| Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis | Q71692071 | ||
| Interleukln-8 stimulates angiogenesis in rats | Q72080099 | ||
| Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice | Q72523009 | ||
| IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor | Q72901004 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| P304 | page(s) | 465-472 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer | |
| P478 | volume | 102 |
| Q57183947 | A dual role for autophagy in a murine model of lung cancer |
| Q36489479 | Adipose tissue-derived stem cells secrete CXCL5 cytokine with chemoattractant and angiogenic properties |
| Q37709556 | Anti-inflammatory agents as cancer therapeutics |
| Q73141316 | Antiangiogenic and antitumor effects of 14-membered ring macrolides on mouse B16 melanoma cells |
| Q35753903 | Association between preeclampsia and the CXC chemokine family (Review). |
| Q30432791 | CXC chemokines in cancer angiogenesis and metastases |
| Q30436563 | CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance |
| Q33562564 | CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes. |
| Q49268237 | CXCL5 as an autocrine or paracrine cytokine is associated with proliferation and migration of hepatoblastoma HepG2 cells |
| Q64118296 | CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer |
| Q53555447 | CXCL5 overexpression is associated with late stage gastric cancer. |
| Q34682656 | CXCL5 plasma levels decrease in patients with chronic liver disease |
| Q52662320 | CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells. |
| Q37341761 | CXCR2 and RET single nucleotide polymorphisms in pancreatic cancer |
| Q27021588 | CXCR2: a target for pancreatic cancer treatment? |
| Q33519806 | Canine CXCL7 and its functional expression in dendritic cells undergoing maturation |
| Q41115229 | Chemokine Expression Profiles of Human Hepatoma Cell Lines Mediated by Hepatitis B Virus X Protein |
| Q35031912 | Chemokine biology in cancer. |
| Q38497234 | Chemokine function in periodontal disease and oral cavity cancer |
| Q26830743 | Chemokine-Derived Peptides: Novel Antimicrobial and Antineoplasic Agents |
| Q37732087 | Chemokines and hepatocellular carcinoma |
| Q36906094 | Chemokines and their receptors in lung cancer progression and metastasis |
| Q30426904 | Chemokines as mediators of angiogenesis. |
| Q30438032 | Chemokines as mediators of neovascularization |
| Q36780595 | Chemokines in the biology of lung cancer. |
| Q34540743 | Chemokines in tumor angiogenesis and metastasis |
| Q34576416 | Chemokines: agents for the immunotherapy of cancer? |
| Q53400230 | Chemokines: not just leukocyte chemoattractants in the promotion of cancer. |
| Q36488894 | Clinical utilization of chemokines to combat cancer: the double-edged sword |
| Q37231517 | Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection. |
| Q36413170 | Contact-dependent carcinoma aggregate dispersion by M2a macrophages via ICAM-1 and β2 integrin interactions. |
| Q39953292 | Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase |
| Q46051126 | Counterpoint: in health and in normoxic environment VO2max is limited primarily by cardiac output and locomotor muscle blood flow |
| Q37400654 | Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis |
| Q43129493 | Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation. |
| Q37979306 | Development of novel CXCR4-based therapeutics |
| Q45275725 | Difference in proangiogenic potential of systemic and pulmonary endothelium: role of CXCR2. |
| Q40842224 | Differential activity of pro-angiogenic CXC chemokines |
| Q46959757 | Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis |
| Q35786924 | Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells |
| Q35855285 | Diversity of the angiogenic phenotype in non-small cell lung cancer |
| Q33346619 | ELR+ CXC chemokine expression in benign and malignant colorectal conditions |
| Q46319754 | ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis |
| Q37413102 | Exploring the role of CHI3L1 in "pre-metastatic" lungs of mammary tumor-bearing mice. |
| Q35215701 | Fibroblast α11β1 integrin regulates tensional homeostasis in fibroblast/A549 carcinoma heterospheroids |
| Q37175083 | G-protein coupled chemoattractant receptors and cancer |
| Q91674866 | Galectin-3 promotes CXCR2 to augment the stem-like property of renal cell carcinoma |
| Q39589654 | Gene expression profiling of the androgen independent prostate cancer cells demonstrates complex mechanisms mediating resistance to docetaxel |
| Q41423380 | Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea. |
| Q38843272 | HOXC10 up-regulation contributes to human thyroid cancer and indicates poor survival outcome |
| Q37532498 | IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer |
| Q38745550 | INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer |
| Q39396200 | Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts |
| Q30438758 | Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment |
| Q43181422 | In vitro and in vivo anti-angiogenic activity of girinimbine isolated from Murraya koenigii |
| Q24649640 | Inflammation and cancer |
| Q36603426 | Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor Microenvironment |
| Q40351368 | K-ras activation generates an inflammatory response in lung tumors |
| Q36511756 | MALAT1 is an oncogenic long non-coding RNA associated with tumor invasion in non-small cell lung cancer regulated by DNA methylation |
| Q34268934 | Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair |
| Q31048838 | Mass homozygotes accumulation in the NCI-60 cancer cell lines as compared to HapMap Trios, and relation to fragile site location |
| Q31133087 | Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis |
| Q33793308 | Molecular pathogenesis of lung cancer |
| Q40791025 | Multi-faceted analyses of a highly metastatic human lung cancer cell line NCI-H460-LNM35 suggest mimicry of inflammatory cells in metastasis. |
| Q36213700 | Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression |
| Q38089079 | New biomarkers for lung cancer |
| Q36958177 | One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment |
| Q37017056 | Ovarian cancer stroma: pathophysiology and the roles in cancer development |
| Q30427989 | Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer |
| Q84405957 | Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma |
| Q34471041 | Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor. |
| Q24804267 | Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis |
| Q34768343 | PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer |
| Q36742274 | Pathophysiology of tumor neovascularization |
| Q35498810 | Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes |
| Q38111715 | Physiological and pathological angiogenesis in the adult pulmonary circulation |
| Q35756907 | Potential for TRAIL as a therapeutic agent in ovarian cancer |
| Q55209569 | Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis. |
| Q42253687 | Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer |
| Q34134446 | Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis |
| Q26796395 | Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation |
| Q35934127 | Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies |
| Q38773484 | Small cell lung cancer: Recruitment of macrophages by circulating tumor cells |
| Q30434154 | Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma |
| Q36083427 | Soluble mediators of inflammation during tumor development |
| Q33634686 | Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate |
| Q35131138 | Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis |
| Q28279309 | Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancer |
| Q35882119 | Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities |
| Q37901025 | Targeting of the innate immunity/inflammation as complementary anti-tumor therapies |
| Q44273260 | The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with interleukin-8/CXCL8. |
| Q47101861 | The clinical significance of CXCL5 in non-small cell lung cancer |
| Q37702536 | The impact of the immune system on tumor: angiogenesis and vascular remodeling |
| Q34385436 | The role of CXC chemokines in the regulation of tumor angiogenesis |
| Q37863514 | The role of chemokines and their receptors in angiogenesis |
| Q29614299 | The role of myeloid cells in the promotion of tumour angiogenesis |
| Q43671920 | The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases |
| Q34016573 | Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo |
| Q92602894 | Transcriptomic Profiling of Adipose Derived Stem Cells Undergoing Osteogenesis by RNA-Seq |
| Q39153235 | Vascular endothelial growth factor induces CXCL1 chemokine release via JNK and PI-3K-dependent pathways in human lung carcinoma epithelial cells |
| Q35913844 | Vascular remodeling in the circulations of the lung |
Search more.